Aviva PLC
03 March 2008
Aviva plc
3 March 2008
For immediate release
NOTIFICATION OF PUBLICATION OF PRELIMINARY RESULTS
The following prospectus supplement has been approved by the UK Listing
Authority and is available for viewing:
Supplement dated 3 March 2008 relating to a £5,000,000,000 Euro Note Programme
established by Aviva plc.
In addition, a copy of the Supplement (together with the information
incorporated therein by reference) has been filed with, and is available for
viewing at the Document Viewing Facility at the Financial Services Authority, 25
The North Colonnade, London E14 5HS.
Enquiries:
Analysts
Charles Barrows, investor relations director +44 (0) 20 7662 8115
Susie Yeoh, investor relations manager +44 (0) 20 7662 2117
Media
Sue Winston, head of group media relations +44 (0) 20 7662 8221
DISCLAIMER - INTENDED ADDRESSEES
Please note that the Supplement supplements and forms part of the base
prospectus dated 27 November 2007 (and any supplements to the such base
prospectus) (the 'Prospectus') relating to the above referenced programme (the
'Programme') and the information contained in the Supplement and the Prospectus
may be addressed to and/or targeted at persons who are residents of particular
countries (specified in the Prospectus) only and is not intended for use and
should not be relied upon by any person outside these countries and/or to whom
any offer of notes under the Programme (the 'Notes') is not addressed. Prior to
relying on the information contained in the Supplement and Prospectus you must
ascertain from the Prospectus whether or not you are part of the intended
addressees of the information contained therein. The Notes have not been and
will not be registered under the United States Securities Act of 1933, as
amended (the 'Securities Act') and are subject to US tax law requirements.
Subject to certain exceptions, the Notes may not be offered, sold or delivered
in the United States or to or for the account of US persons (as defined in
Regulation S under the Securities Act).
Your right to access this service is conditional upon complying with the above
requirement. To view the full document, please paste the following URL into the
address bar of your browser.
http://www.rns-pdf.londonstockexchange.com/rns/2450p_-2008-3-3.pdf
END
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.